Top

Published in:

01-09-2020 | Coronavirus | Review

Neurological manifestations of COVID-19: a review of what we know so far

Author: Panagiotis Gklinos

Published in: Journal of Neurology | Issue 9/2020

Abstract

Coronavirus disease 2019 (COVID‐19) has become a pandemic disease globally. While it mostly presents with respiratory symptoms, it has already been found that it could manifest with a series of neurological symptoms as well, either at presentation or during the course of the disease. Symptoms vary from non-specific such as headache or dizziness to more specific such as convulsions and cerebrovascular disease (CVD). This study aims to give an overview of the neurological manifestations of COVID-19 and discuss the potential pathogenetic mechanisms of central nervous system (CNS) involvement. Clinicians and especially internists, neurologists, and infectious disease specialists should be aware of these symptoms and able to recognize them early. Prompt diagnosis and immediate management of the neurological manifestations of the novel coronavirus will not only improve the prognosis of COVID-19 patients but will also prevent the dissemination of the disease due to misdiagnosed cases.

Mahase E (2020) Covid-19: WHO declares pandemic because of “larming levels” of spread, severity, and inaction. BMJ 368:1036CrossRef

Zhao Y, Zhao Z, Wang Y et al (2020) Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. BioRxiv. https://doi.org/10.1101/2020.01.26.919985CrossRefPubMedPubMedCentral

Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W et al (2003) A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348:1953–1966CrossRefPubMed

Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P et al (2020) Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 27(3):325–328CrossRefPubMedPubMedCentral

Cyranoski D (2020) Did pangolins spread the China coronavirus to people? Nature 2020.

Yong Z, Cao C, Shuangli Z et al (2020) Notes from the field: isolation of 2019-nCoV from a stool specimen of a Laboratory-confirmed case of the coronavirus disease 2019 (COVID-19). China CDC Weekly 2:123–124

Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, Ueno M, Sakata H, Kondo K, Myose N, Nakao A, Takeda M, Haro H, Inoue O, Suzuki-Inoue K, Kubokawa K, Ogihara S, Sasaki T, Kinouchi H, Kojin H, Ito M, Onishi H, Shimizu T, Sasaki Y, Enomoto N, Ishihara H, Furuya S, Yamamoto T, Shimada S (2020) A first case of Meningitis/Encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. https://doi.org/10.1016/j.ijid.2020.03.062CrossRefPubMedPubMedCentral

Xiang P, Xu XM, Gao LL, Wang HZ, Xiong HF, Li RH et al (2020) First case of 2019 novel coronavirus disease with encephalitis. ChinaXiv 202003:00015

Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S (2020) Brent Griffith; COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI. Radiology 31:201187. https://doi.org/10.1148/radiol.2020201187CrossRef

10.

Rossi A (2008) Imaging of acute disseminated encephalomyelitis. Neuroimaging Clin 18(1):149–161CrossRef

11.

Filatov A, Sharma P, Hindi F et al (2020) Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus 12(3):e7352. https://doi.org/10.7759/cureus.7352CrossRefPubMedPubMedCentral

12.

Li Y, Wang M, Zhou Y, Chang J, Xian Y, Mao L, Hong C, Chen S, Wang Y, Wang H, Li M, Jin H, Hu B (2020) Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study (3/3/2020). Doi: 10.2139/ssrn.3550025

13.

Mao L, Wang M, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Li Y, Jin H, Hu B (2020) Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. MedRxiv 2020.02.22.20026500. Doi: 10.1101/2020.02.22.20026500

14.

Suzuki M, Saito K, Min WP, Vladau C, Toida K, Itoh H, Murakami S (2007) Identification of viruses in patients with post- viral olfactory dysfunction. Laryngoscope 117(2):272–277CrossRefPubMedPubMedCentral

15.

Van Riel D, Verdijk R, Kuiken T (2015) The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. J Pathol 235(2):277–287. https://doi.org/10.1002/path.4461CrossRefPubMed

16.

Welge-Lussen A, Wolfensberger M (2006) Olfactory disorders following upper respiratory tract infections. Taste and smell, 63. Karger Publishers 2006:125–132

17.

Lechien JR, Chiesa-Estomba CM, De Siati DR et al (2020) Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. https://doi.org/10.1007/s00405-020-05965-1CrossRefPubMedPubMedCentral

18.

Zhao H, Shen D, Zhou H, Liu J, Chen S (2020) Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. pii: S1474-4422(20)30109-5. doi: 10.1016/S1474-4422(20)30109-5.

19.

Metlay JP, Waterer GW, Long AC et al (2019) Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the American Thoracic Society and Infectious Disease Society of America. Am J Respir Crit Care Med 200:e45–e67CrossRefPubMedPubMedCentral

20.

Desforges M, Le Coupanec A, Dubeau P et al (2020) Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses 12:14CrossRef

21.

Desforges M, Le Coupanec A, Brison E et al (2014) Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans. Adv Exp Med Biol 807:75–96CrossRefPubMedPubMedCentral

22.

Tsai LK, Hsieh ST, Chang YC (2005) Neurological manifestations in severe acute respiratory syndrome. Acta Neurol Taiwan 14(3):113–119PubMed

23.

Hung EC, Chim SS, Chan PK et al (2003) Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem 49:2108–2109CrossRefPubMedPubMedCentral

24.

Gu J, Gong E, Zhang B et al (2005) Multiple organ infection and the pathogenesis of SARS. J Exp Med 202(3):415–424CrossRefPubMedPubMedCentral

25.

Kim JE, Heo JH, Kim HO, Song SH, Park SS, Park TH et al (2017) Neurological complications during treatment of middle east respiratory syndrome. J Clin Neurol 13(3):227–233CrossRefPubMedPubMedCentral

26.

Berth SH, Leopold PL, Morfini GN (2009) Virus-induced neuronal dysfunction and degeneration. Front Biosci 14:5239–5259CrossRef

27.

Swanson PA, McGavern DB (2015) Viral diseases of the central nervous system. Curr Opin Virol 11:44–54CrossRefPubMedPubMedCentral

28.

Koyuncu OO, Hogue IB, Enquist LW (2013) Virus infections in the nervous system. Cell Host Microbe 13(4):379–393. https://doi.org/10.1016/j.chom.2013.03.010CrossRefPubMedPubMedCentral

29.

Bohmwald K, Galvez NMS, Rios M, Kalergis AM (2018) Neurologic alterations due to respiratory virus infections. Front Cell Neurosci 12:386CrossRefPubMedPubMedCentral

30.

Wang Y, Wang Y, Chen Y, Qin Q (2020) Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 92(6):568–576CrossRefPubMed

31.

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033–1034CrossRefPubMedPubMedCentral

Title: Neurological manifestations of COVID-19: a review of what we know so far
Author: Panagiotis Gklinos
Publication date: 01-09-2020
Publisher: Springer Berlin Heidelberg
Keywords: Coronavirus
Guillain-Barré Syndrome
Severe Acute Respiratory Syndrome Coronavirus
SARS-CoV-2
COVID-19
Encephalitis
Published in: Journal of Neurology / Issue 9/2020
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-020-09939-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Neurological manifestations of COVID-19: a review of what we know so far

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2020

An integrated perspective linking physiological and psychological consequences of mild traumatic brain injury

Bi-allelic variants in PNPLA6 possibly associated with Parkinsonian features in addition to spastic paraplegia phenotype

Dopaminergic function in spinocerebellar ataxia type 6 patients with and without parkinsonism

Pick’s disease: clinicopathologic characterization of 21 cases

Advantages of timing the duration of a freezing of gait-provoking test in individuals with Parkinson’s disease

Epilepsy in children with leukodystrophies